These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27933585)

  • 21. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel hard capsule prepared by tilapia (Oreochromis niloticus) scale gelatin and konjac glucomannan: Characterization, and in vitro dissolution.
    Liu Y; Li B; Zhang K; Li J; Hou H
    Carbohydr Polym; 2019 Feb; 206():254-261. PubMed ID: 30553320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microneedles assisted controlled and improved transdermal delivery of high molecular drugs via
    Khan S; Minhas MU; Singh Thakur RR; Aqeel MT
    Drug Dev Ind Pharm; 2022 Jun; 48(6):265-278. PubMed ID: 35899871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G; Csontos B; Sovány T; Regdon G; Bényei A; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Nguyen TLP; Vecsernyés M; Fenyvesi F
    AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suitability of phosphatidylcholine-based formulations for liquid filling in hard capsules.
    Grüne L; Bunjes H
    Eur J Pharm Sci; 2020 Oct; 153():105470. PubMed ID: 32682932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
    Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
    Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
    Ur-Rehman T; Tavelin S; Gröbner G
    Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
    Liu Y; Zhu YY; Wei G; Lu WY
    Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the optimal amount of water in liquid-fill masses for hard gelatin capsules by means of texture analysis and experimental design.
    Kuentz M; Röthlisberger D
    Int J Pharm; 2002 Apr; 236(1-2):145-52. PubMed ID: 11891078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
    Crum M; Elkordy AA; Zarara M; Elkordy EA
    Pharm Dev Technol; 2013; 18(6):1379-90. PubMed ID: 22992055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
    Li XY; Zhu ZJ; Cheng AY
    Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of κ-carrageenan on rheological properties of dually modified sago starch: Towards finding gelatin alternative for hard capsules.
    Fakharian MH; Tamimi N; Abbaspour H; Mohammadi Nafchi A; Karim AA
    Carbohydr Polym; 2015 Nov; 132():156-63. PubMed ID: 26256336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of drugs formulated as hard pastes filled into hard gelatin capsules. Part 1. Physical properties and in vitro testing.
    Djimbo M; Moës AJ
    J Pharm Belg; 1984; 39(1):36-42. PubMed ID: 6726605
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation and characterization of pluronic-colloidal silicon dioxide composite particles as liquid crystal precursor.
    Maheshwari M; Paradkar A; Yamamura S; Kadam S
    AAPS PharmSciTech; 2006; 7(4):92. PubMed ID: 17285743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
    Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
    Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of ointments with highly dispersed silicon dioxide. 2. Colloid physical and rheological stability of gels containing Aerosil and Syloid].
    Töricht E; Erös I
    Pharmazie; 1977 Mar; 32(3):169-71. PubMed ID: 194266
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.